Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Peter van Rooij"'
Autor:
Abrahim Al-Mamgani, Peter van Rooij, Gerda M. Verduijn, Lisa Tans, S.L.S. Kwa, Robert Mehilal
Publikováno v:
European Archives of Oto-Rhino-Laryngology, 271(1), 125-132. Springer-Verlag
The objective of the presented study is to report on retrospectively collected data on long-term outcome and toxicity and prospective assessment of quality of life (QoL) and Voice-Handicap Index (VHI) of patients with T1a glottic cancer treated with
Autor:
Peter C. Levendag, David N. Teguh, Peter van Rooij, Cees A. Meeuwis, Abrahim Al-Mamgani, Aniel Sewnaik
Publikováno v:
Head & Neck. 35:1689-1697
Background The purpose of this study was to reduce the incidence of radiation-induced toxicity in patients with early-stage oropharyngeal cancer, using highly conformal radiation techniques. Methods Between 2000 and 2011, 167 patients with T1-3N0-3 o
Publikováno v:
European Archives of Oto-Rhino-Laryngology
European Archives of Oto-Rhino-Laryngology, 270(1), 293-299. Springer-Verlag
European Archives of Oto-Rhino-Laryngology, 270(1), 293-299. Springer-Verlag
The optimal treatment of sinonasal undifferentiated carcinoma (SNUC) remains unclear. We report our results on the outcome and toxicity of patients with SNUC treated by a combined modality and attempt to define the optimal treatment strategies by rev
Publikováno v:
Radiotherapy and Oncology, 106(1), 69-73. Elsevier Ireland Ltd
Background and purpose To investigate the impact of unilateral neck irradiation (UNI) of well-lateralized oropharyngeal cancer (OPC) on outcome and toxicity. Materials and methods Unilateral neck IMRT was applied to 185 consecutive patients with well
Autor:
Robert Mehilal, Peter C. Levendag, Peter van Rooij, Abrahim Al-Mamgani, Jeroen D. F. Kerrebijn, Gerda M. Verduijn
Publikováno v:
Laryngoscope, 123(2), 386-393. Wiley-Blackwell
Objectives/Hypothesis: To investigate the impact of treatment modality and radiation technique on oncologic outcomes and toxicity of patients with locally advanced oropharyngeal cancer (OPC). Study Design: Retrospective analysis of outcomes and toxic
Autor:
Gerda M. Verduijn, Aniel Sewnaik, Peter van Rooij, Robert J. Baatenburg de Jong, Robert Mehilal, Lisa Tans, Abrahim Al-Mamgani
Publikováno v:
Oral Oncology, 49(10), 1018-1024. Elsevier Ltd.
Summary Objectives To compare outcome, toxicity and QoL of two boost modalities for T1-2 oropharyngeal carcinoma (OPC). Materials and methods Between 2000 and 2012, 250 consecutive patients with T1-2N0-3 were treated with 46-Gy of IMRT followed by bo
Autor:
Gerda M. Verduijn, Robert J. Baatenburg de Jong, Lisa Tans, Abrahim Al-Mamgani, Peter van Rooij, Aniel Sewnaik
Publikováno v:
Radiotherapy and Oncology, 106(3), 359-363. Elsevier Ireland Ltd
Background and purpose To prospectively investigate the impact of different patients' characteristics on quality-of-life (QoL) after (chemo)radiation for oropharyngeal cancer (OPC). Materials and methods Between 2008 and 2011, 207 patients were treat
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 83(3), 1000-1006. Elsevier Inc.
Purpose To retrospectively analyze the outcomes, toxicity, quality of life, and voice quality of patients with T3 laryngeal cancer treated with radiotherapy and to identify subgroups of patients in whom the addition of chemotherapy to radiotherapy is
Autor:
Peter C. Levendag, Fatma Keskin-Cambay, Sarah O.S. Osman, Eleftheria Astreinidou, Abrahim Al-Mamgani, Dominique A. Monserez, Ben J.M. Heijmen, Peter van Rooij, David N. Teguh, S.L.S. Kwa
Publikováno v:
Radiotherapy and Oncology, 101(3), 415-419. Elsevier Ireland Ltd
Introduction: The treatment of choice for early glottic cancer is still being debated; ultimately it relies on the functional outcome. This paper reports on a novel sparing 4D conformal technique for single vocal cord irradiation (SVCI). Material and
Autor:
Peter van Rooij, Wim J. Kirkels, Inger-Karine K. Kolkman-Deurloo, Luca Incrocci, Chris H. Bangma, Misha Hoogeman, Shafak Aluwini
Publikováno v:
Journal of Endourology, 24(5), 865-869. Mary Ann Liebert Inc.
Purpose: The CyberKnife (CK), a linear accelerator mounted on a robotic device, enables excellent dose conformation to the target and minimizes dose to surrounding normal tissue. It is a very suitable device for performing hypofractionated stereotact